Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17631866 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: NRP104;   Drug: Adderall XR;   Drug: Placebo

Indicates status has not been verified in more than two years